(Q46448409)

22 December 2017

title

Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes (English)

1 reference

22 December 2017

0 references

0 references

1 reference

I Chapman

1

1 reference

22 December 2017

B Parker

2

1 reference

22 December 2017

S Doran

3

1 reference

22 December 2017

C Feinle-Bisset

4

1 reference

22 December 2017

J Wishart

5

1 reference

22 December 2017

S Strobel

6

1 reference

22 December 2017

Y Wang

7

1 reference

22 December 2017

C Burns

8

1 reference

22 December 2017

C Lush

9

1 reference

22 December 2017

C Weyer

10

1 reference

22 December 2017

M Horowitz

11

1 reference

22 December 2017

publication date

21 April 2005

1 reference

22 December 2017

published in

Diabetologia

1 reference

22 December 2017

volume

48

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

838-848

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s00125-005-1732-4

exact match

0 references

cites work

Amylin receptor blockade stimulates food intake in rats

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-005-1732-4

Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion

21 January 2018

1 reference

12 December 2020

Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men

1 reference

12 December 2020

Amylin decreases meal size in rats

1 reference

12 December 2020

Oxyntomodulin suppresses appetite and reduces food intake in humans

1 reference

12 December 2020

An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3

1 reference

12 December 2020

Gut hormone PYY(3-36) physiologically inhibits food intake

1 reference

12 December 2020

The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger.

1 reference

12 December 2020

Gastrointestinal correlates of the development of hunger in man.

1 reference

12 December 2020

Inhibition of food intake in obese subjects by peptide YY3-36

1 reference

12 December 2020

The gut and regulation of body weight

1 reference

12 December 2020

Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial

1 reference

12 December 2020

Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging

1 reference

12 December 2020

A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes

1 reference

12 December 2020

Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2.

1 reference

12 December 2020

The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats

1 reference

12 December 2020

Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps

1 reference

12 December 2020

Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin.

1 reference

12 December 2020

Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus

1 reference

12 December 2020

The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients

1 reference

12 December 2020

Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide

1 reference

12 December 2020

Amylin: a novel action in the brain to reduce body weight

1 reference

12 December 2020

The pharmacology of human appetite expression.

1 reference

12 December 2020

Inhibition of central amylin signaling increases food intake and body adiposity in rats

1 reference

12 December 2020

Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study

1 reference

12 December 2020

Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee

1 reference

12 December 2020

C-Terminal octapeptide of cholecystokinin decreases food intake in obese men☆☆☆

1 reference

12 December 2020

High affinity amylin binding sites in rat brain

1 reference

12 December 2020

Ghrelin enhances appetite and increases food intake in humans

1 reference

12 December 2020

Central regulators of food intake

1 reference

12 December 2020

Effects of cholecystokinin on appetite and pyloric motility during physiological hyperglycemia

1 reference

12 December 2020

Amylin and insulin interact to reduce food intake in rats

1 reference

12 December 2020

Physical state of meal affects gastric emptying, cholecystokinin release and satiety

1 reference

12 December 2020

Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control

1 reference

12 December 2020

A satiety quotient: a formulation to assess the satiating effect of food.

1 reference

12 December 2020

Minireview: Gut peptides regulating satiety.

1 reference

12 December 2020

Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men

1 reference

12 December 2020

In vitro autoradiographic localization of amylin binding sites in rat brain

1 reference

12 December 2020

Effect of the menstrual cycle on energy and nutrient intake

1 reference

12 December 2020

Trends in intake of energy and macronutrients--United States, 1971-2000.

1 reference

12 December 2020

Unresolved challenges with insulin therapy in type 1 and type 2 diabetes: potential benefit of replacing amylin, a second beta-cell hormone

1 reference

12 December 2020

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

1 reference

12 December 2020

Pancreatic polypeptide reduces appetite and food intake in humans

1 reference

12 December 2020

Effects of somatostatin on human satiety

1 reference

12 December 2020

Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetes

1 reference

12 December 2020

10.1007/S00125-005-1732-4

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

15843914

1 reference

22 December 2017